Picture of Sino Biopharmaceutical logo

1177 Sino Biopharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Deals of the day-Mergers and acquisitions

Adds: Sino Biopharmaceutical, Israir, Zeekr

July 15 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:

** Hong Kong-listed Sino Biopharmaceutical <1177.HK> said it will buy the remaining 95.09% stake it does not hold in Shanghai-based LaNova Medicines for no more than $950.92 million.

nL4N3TC0XE

** Israeli carrier Israir  said it was buying 20% of a local credit card company for 40 million shekels ($12 million) in a bid to grow its passenger base.

nL1N3TC0E0

** Chinese electric vehicle firm Zeekr said it would be acquired by Geely Automobile Holdings.

nL4N3TC0SQ

**Scandinavian property companies Pandox AB  and Eiendomsspar AS  have agreed to buy Ireland's largest hotel group Dalata  for 1.4 billion euros ($1.64 billion), the companies said.

[nL4N3TC0GS ]

** K2 Insurance Services is selling its Gene Mason-led Aegis Pro Risk portfolio, a book of business originally launched in late 2020 offering $5 million in primary and excess capacity, to The McGowan Companies, wholesale and program manager sources confirmed.

nL6N3TB0PI

 (Compiled by Rajarshi Roy and Ateev Bhandari in Bengaluru)

 ((Ateev.Bhandari@thomsonreuters.com))

Recent news on Sino Biopharmaceutical

See all news